$TRT

ADELMAN JASON T sold $154K of TRT

ADELMAN JASON T sold 10,000 shares of TRIO-TECH INTERNATIONAL (TRT) at an average of $15.36 ($14.88–$15.84, $0.15M total) across 2 trades over 2026-06-18 to 2026-06-19.

Original reporting
SEC EDGAR · ADELMAN JASON T
Published Jun 23, 2026, 6:34 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 6:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$TRT
Neutral
medium confidence
Mentioned
$TRT
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$TRTNeutralLow
01

Why it matters

A director’s open-market sale is disclosed with trade dates and price range, but the filing does not include new company fundamentals or guidance.

02

Market read

Traders may note insider selling as a mild sentiment input, but there is no new fundamental catalyst in the text.

03

What to watch

The trades occurred 3–5 days before filing; without context on total holdings, diversification needs, or tax events, signal strength is weak.

Relevance 4/10Novelty 3/10Timing: filed after-hours/late day (2026-06-23) for trades dated 2026-06-18 to 2026-06-19

Background

The article is an SEC Form 4 insider transaction disclosure for TRIO-TECH INTERNATIONAL (TRT).

Company-level read

Ticker impact

$TRTNeutralMedium confidence
Context

SEC Form 4 shows director Jason T. Adelman sold 10,000 shares of TRIO-TECH INTERNATIONAL (TRT) for ~$153.6K at $14.88–$15.84.

Expected impact

Likely limited/short-lived impact; any move would be more sentiment-driven than fundamental.

Evidence & confidence

The filing is a disclosed sale (not a buy), but it’s not tied to a new operational/regulatory event and is relatively small in absolute market terms.

Market effects

No sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Director sales can be pre-planned for liquidity/tax and may not reflect bearish expectations, especially with no 10b5-1 plan stated.

Key entities

  • TRIO-TECH INTERNATIONAL

    Company whose director sold shares via open-market transactions disclosed on Form 4.

  • ADELMAN JASON T

    Director who sold 10,000 shares of TRT for ~$153.6K.

Related articles

$TRTMedAI 8/10

Don’t be fooled by London’s takeover premiums

The article says US IPOs from Anthropic, SpaceX and OpenAI could change S&P index composition. In London, it reports more overseas takeover bids for FTSE firms: Intertek accepted EQT’s £10.6bn offer after rejecting earlier bids; Tate & Lyle received £2.7bn from Ingredion; Treatt accepted £183mn from Döhler; Senior agreed a £1.4bn deal led by Tinicum and Blackstone. It links reduced listings and liquidity concerns to weaker funding access.